Lyka Labs Quarterly Results for Trading Insights
LYKALABS • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-3 Cr
QSept 2025
Lyka Labs Quarterly Results Key Highlights
- Revenue of ₹38 Cr in Sept 2025 (+11.8% vs Mar 2025, -7.3% vs Sept 2024)
- Net Profit of ₹-3 Cr in Sept 2025 (-250.0% vs Mar 2025, -250.0% vs Sept 2024)
- EBITDA of ₹-2 Cr in Sept 2025 (-140.0% vs Mar 2025)
- Operating Margin of -7.0% in Sept 2025 (-19.0pp vs Mar 2025)
- Earnings Per Share of ₹-0.94 in Sept 2025 (-291.8% vs Mar 2025)
Lyka Labs Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 38 | 34 | 34 | 32 | 41 | 11.8% | -7.3% |
| Net Profit (₹ Cr) | -3 | 2 | 1 | 0 | 2 | - | - |
| EBITDA (₹ Cr) | -2 | 5 | 4 | 3 | 5 | - | - |
| EPS (₹) | -0.94 | 0.49 | 0.25 | 0.00 | 0.58 | - | - |
| Operating Margin (%) | -7.0% | 12.0% | 11.0% | 5.0% | 12.0% | - | - |
Lyka Labs Share Price Trend Around Quarterly Results
Visualize Lyka Labs's 1-year price movement across quarterly results — ideal for logging trades in Lyka Labs share price
chart using Tickjournal. All values in ₹.
Related Pages for Lyka Labs
Additional stock information and data for LYKALABS
Revenue Trend (₹ Cr)
Dec 2025
32
Jun 2025
34
Mar 2025
34
Sept 2025
38
Net Profit Trend (₹ Cr)
Dec 2025
0
Jun 2025
1
Mar 2025
2
Sept 2025
-3
Operating Margin Trend (%)
Dec 2025
5.0%
Jun 2025
11.0%
Mar 2025
12.0%
Sept 2025
-7.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Lyka Labs quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹438,094.57 Cr | 1825.3 | 14,875 | 3,125 | +10.8% | - | 21.0% | 140.4 |
|
Divis Laboratories
Sept 2025 |
₹167,616.86 Cr | 6282.0 | 2,860 | 689 | +7.1% | - | 24.1% | 241.9 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,025.88 Cr | 4446.0 | 3,219 | 591 | +11.3% | - | 18.4% | 253.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹110,630.25 Cr | 1319.0 | 9,135 | 1,337 | +1.1% | - | 14.6% | 81.5 |
|
Cipla
Sept 2025 |
₹107,029.80 Cr | 1324.3 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.2 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores